Nanobacteria - Propagating calcifying nanoparticles

Letters in Applied Microbiology

Volumn 42, Issue 6, 2006, Pages 549-552

  Kajander, E O ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Nanobac Pharmaceuticals Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH;

'CURRENT; HUMAN DISEASE; IN-VITRO; INFECTIOUS AGENTS; LIVING ORGANISMS; MATCHINGS;

NANOPARTICLES;

NANOPARTICLE;

BACTERIA; BACTERIOLOGY; CALCIFICATION (BIOCHEMISTRY); CELL CULTURE; DISEASES; HEALTH HAZARDS; PATHOLOGY;

BACTERIUM; CALCIFICATION; CELL ORGANELLE; DISEASE; HEALTH IMPACT; MORTALITY;

ARTICLE; BACTERIAL CELL; BIOFILM; CELL DEATH; ESCHERICHIA COLI; NONHUMAN; RHIZOBIUM RADIOBACTER;

AGROBACTERIUM TUMEFACIENS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33646880820     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2006.01945.x     Document Type: Article

References (30)

1. Aho K.M. Kajander E.O. 2003 Pitfalls in the detection of novel nanoorganisms. J Clin Microbiol 41, 3460 3461.
2. Aho K.M. Kajander E.O. Çiftçioglu N. 2005 A novel multiplex-like ELISA test reveals that both Gla-clotting and anti-calcification proteins are present on calcifying nano-particles. The ASCB, 45th Annual Meeting, December 10-14, San Francisco 2005. Abstract No. 722.
3. Aho K. Kajander E.O. Çiftçioglu N. Hjelle J.T. Miller-Hjelle M.A. 2002 Screening of human gamma globulin products for nanobacteria markers. In American Society for Microbiology 102 General Meeting Abstracts p. 507. Washington : American Society for Microbiology.
4. Anon 2001 Nanobacteria are present in vaccines, but any health risks remain unknown. Medical Letter on the CDC & FDA; 06/10/2001, p. 19.
5. Aoki H. Aoki H. 1996 Acute toxicity of hydroxyapatite microcrystal suspension by intravenous injection in rats. In Transactions of the Annual Meeting of the Society for Biomaterials in Conjugation with the International Biomaterials p. 357. St Louis Park : Society for Biomaterials.
6. Çiftçioglu N. Kajander E.O. 2000 Nanobacterial growth factor. SPIE Proc 3755, 113 119.
7. Çiftçioglu N. Çiftçioglu V. Vali H. Turcott E. Kajander E.O. 1998 Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria. SPIE Proc 3441, 130 136.
8. Çiftçioglu N. Haddad R.S. Golden D.C. Morrison D.R. McKay D.S. 2005 A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 67, 483 491.
9. Cisar J.O. Xu D.-Q. Thompson J. Swaim W. Hu L. Kopecko D.J. 2000 An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97, 11511 11515.
10. Cuerpo G.E. Kajander E.O. Çiftçioglu N. Castellano L.F. Correa C. Gonzalez J. Mampaso F. Liano F. et al. 2000 Nanobacteria. Un modelo de neo-litogenesis experimental. Arch Esp Urol 53, 291 303.
11. Ertas F. Hasan T. Akan O. Ozdol C. Uysal S. Tulunay C. Kocum T. Sahin M. et al. 2006 Antinanobacterial antibody titer is an independent risk factor for coronary artery calcification. Abstract presented at the ACC, 55th Annual Scientific Session, March 14, 2006, Atlanta. JACC, In press.
12. Hjelle J.T. Miller-Hjelle M.A. Poxton I.R. Kajander E.O. Çiftçioglu N. Jones M.L. Caughey R.C. Brown R. et al. 2000 Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57, 2360 2374.
13. Hudelist G. Singer C.F. Kubista E. Manavi M. Mueller R. Pischinger K. Czerwenka K. 2004 Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 45, 633 637.
14. Jelic T.M. Malas A.M. Groves S.S. Jin B. Mellen P.F. Osborne G. Roque R. Rosencrance J.G. et al. 2004 Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 97, 194 198.
15. Kajander E.O. Çiftçioglu N. 1998 Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95, 8274 8279.
16. Kajander E.O. Çiftçioglu N. Aho K. 2001 Detection of nanobacteria in viral vaccines. In American Society for Microbiology 101 General Meeting Abstracts p. 736. Washington : American Society for Microbiology.
17. Kajander E.O. Harinen S.H. Aho K.M. 2005 Nanobacterial mixed-biofilm formation with Agrobacterium tumefaciens and E. coli. In American Society for Microbiology 105 General Meeting Abstracts, Abstract I-085. Washington : American Society for Microbiology.
18. Khullar M. Sharma S.K. Singh S.K. Bajwa P. Sheikh F.A. Relan V. Sharma M. 2004 Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 32, 190 195.
19. Maniscalco B.S. Taylor K.A. 2004 Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11, 95 101.
20. Miller V.M. Rodgers G. Charlesworth J.A. Kirkland B. Severson S.R. Rasmussen T.E. Yagubyan M. Rodgers J.C. et al. 2004 Evidence of nanobacterial-like structures in human calcified arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287, H1115 H1124.
21. Pretorius A.M. Sommer A.P. Aho K.M. Kajander E.O. 2004 HIV and nanobacteria. HIV Med 5, 391 393.
22. Puskas L.G. Tiszlavicz L. Razga Z. Torday L.L. Krenacs T. Papp J.G. 2005 Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56, 233 245.
23. Sedivy R. Battistutti W.B. 2003 Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111, 951 954.
24. Shiekh F.A. Khullar M. Singh S.K. 2006 Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34, 53 57.
25. Shoskes D.A. Thomas K.D. Gomez E. 2005 Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 173, 474 477.
26. Sommer A.P. McKay D.S. Çiftçioglu N. Oron U. Mester A.R. Kajander E.O. 2003 Living nanovesicles: chemical and physical survival strategies of primordial biosystems. J Proteome Res 2, 441 443.
27. Wen Y. Li Y.-G. Yang Z. Wei H. Liu W. Tan A. Miao X. Wang Q. et al. 2002 Culture and identification of nanobacteria in bile. Zhonghua Yi Xue Za Zhi 82, 1557 1560.
28. Wen Y. Li Y.G. Yang Z.L. Wang X.J. Wei H. Liu W. Tan A.L. Miao X.Y. et al. 2003 Nanobacteria in serum, bile and gallbladder mucosa of cholecystolithiasis patients. Zhonghua Wai Ke Za Zhi 41, 267 270.
29. Zhou H.D. Li G.Y. Yang Y.X. Li X.L. Sheng S.R. Zhang W.L. Zhao J. 2006 Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol, in press.
30. Zhu J. Kajander E.O. Katz R.J. Çiftçioglu N. Canos D.A. Pinnow E.E. Famogun Y. Pichard A. et al. 2004 Increased serum levels of nanobacteria antibodies are associated with high coronary calcification score. Circ Suppl 110, 627.